Octreotide Infusion for the Treatment of Congenital Chylothorax
Joint Authors
Kobeisy, Sumayyah Ahmed Nezar
Alkhotani, Abdulaziz
Barzanji, Mohammed M.
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-11-11
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Congenital chylothorax is an uncommon cause of pleural effusion in the pediatric age group, and it should be kept in consideration when evaluating a neonate with pleural effusion, as it is the commonest cause of pleural effusion in this age group (Tutor, 2014).
No commonly accepted guidelines have been published so far regarding the management of congenital chylothorax in the neonate, but trials of octreotide have appeared to be promising (Bellini et al., 2018).
We present a neonate with congenital chylothorax successfully treated with octreotide infusion.
American Psychological Association (APA)
Kobeisy, Sumayyah Ahmed Nezar& Alkhotani, Abdulaziz& Barzanji, Mohammed M.. 2020. Octreotide Infusion for the Treatment of Congenital Chylothorax. Case Reports in Pediatrics،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1150840
Modern Language Association (MLA)
Kobeisy, Sumayyah Ahmed Nezar…[et al.]. Octreotide Infusion for the Treatment of Congenital Chylothorax. Case Reports in Pediatrics No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1150840
American Medical Association (AMA)
Kobeisy, Sumayyah Ahmed Nezar& Alkhotani, Abdulaziz& Barzanji, Mohammed M.. Octreotide Infusion for the Treatment of Congenital Chylothorax. Case Reports in Pediatrics. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1150840
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1150840
